US English UK English Polish Italian Hungarian Greek Spanish German Australian English


   
in the news

understanding
your tests

inside the lab

about this site

site map

send us your
comments


home
Guillain-Barre Syndrome
Also referred to as: Infectious polyneuritis, Acute inflammatory demyelinating polyneuropathy, Landry's ascending paralysis

What is it?
Guillain-Barre Syndrome (GBS) is an acute condition that involves progressive muscle weakness or paralysis. It is an autoimmune disorder in which the body’s immune system attacks its own nervous system, causing inflammation that damages the cover (myelin sheath) of the nerve. This damage (called demyelinazation) slows or stops the conduction of impulses through the nerve. The impairment of nerve impulses to the muscles leads to symptoms that may include muscle weakness, paralysis, spasms, numbness, tingling or pins-and-needle sensations, and/or tenderness. Affected patients may become so weak that they have trouble breathing and their heart rate becomes abnormal.

Guillain-Barre Syndrome it is a relatively rare condition. According to the National Institute of Neurological Disorders and Stroke (NINDS), about 1 person in 100,000 will have GBS. It can affect anyone at any age. It is an unusual neuropathy in that it spontaneously reverses and most patients recover most or all of the lost nerve and muscle function.

The exact cause of GBS and why it affects one person and not another is not well understood. The autoimmune process may be spontaneous or may be triggered by some specific disease or exposure. Cases have been seen in patients who have had various viral and bacterial infections including HIV infection, in patients with chronic diseases such as lupus (SLE), Hodgkin lymphoma (and some other malignancies), and in patients who recently had a vaccination (such as for rabies or swine flu).


Related Pages
On This Site

Elsewhere On The Web

This article last reviewed on February 11, 2007.
 
In the NewsUnderstanding Your TestsInside the Lab
About the SiteSite MapSend Us Your CommentsHome


We comply with the HONcode standard for trustworthy health
information:
verify here.


©2001-2008 American Association for Clinical Chemistry
Email concerns to

Terms of UsePrivacy